FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. - Wikidata - awgldk - TriplyDB

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

http://www.wikidata.org/entity/Q43115752

about

Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.A place for precision medicine in bladder cancer: targeting the FGFRs.Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis.Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus.Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.The role of genomics in the management of advanced bladder cancer.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.Systemic therapy for metastatic bladder cancer in 2016 and beyond.Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status.Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.Role of Non-Coding RNAs in the Etiology of Bladder Cancer.The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.Differential Expression of FGFRs Signaling Pathway Components in Bladder Cancer: A Step Toward Personalized Medicine.FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis

P2860

Q27853178-582E2671-8FFB-46F8-915D-1AED8CD50E78 Q30249143-E2555869-B8FF-42AE-9D52-2F45F117F813 Q33646072-1D14A794-5DF0-4F7B-AD18-C2387A6EAE67 Q33686468-60997073-237E-400F-B904-EDA6901044EE Q36189141-45C1F1AB-EF56-47BC-8763-1CDBB83760B0 Q36215971-31EF4274-A593-4890-A390-6C2776A4B174 Q36528389-2716A1BF-D55D-4138-8D7C-6DBC82A7C1B6 Q37567109-DEDE5FDA-2963-435F-9F3A-0C1A4E3D9DE7 Q38342992-68F6BEB6-3300-4877-91C9-5C3B73A55618 Q38627721-0EEC8764-67F9-453B-8691-B12E79DC8B05 Q38729065-2BE1C1FF-B777-49FF-85DB-0AD9F7B474F1 Q38753358-1960D9E8-DC3E-452B-BAE4-50D551CFA9C7 Q38810603-92157D6C-FA84-4C10-A270-3ED033BDD6F2 Q38946859-7697A4CE-64CD-4648-9E3F-DAE958020DDA Q39863683-5896D812-B698-4F4C-A2FB-73F523714FBF Q41621271-1FD92852-46CF-463A-9013-9311EF1C6989 Q42694284-E11DB269-EAB3-494A-8A73-EF1273CCFCCF Q43148228-395FD4F4-DF86-400D-BB96-D6ABEAA57D1F Q46236214-F8FD1744-3B65-4CE8-9B4F-86F840B718D9 Q50049202-1F009BE3-CBE5-4539-977A-EF03F604EA7C Q54985778-03994E75-C410-40A5-B53B-2ECDC1A0321F Q55052397-2FE676D1-CE2B-42E0-B690-07163940966E Q58780441-7028E314-C3AA-4A6C-B687-8FD064AAECEA

P2860

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

http://www.wikidata.org/entity/Q43115752

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@en

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@nl

type

label

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@en

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@nl

prefLabel

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@en

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@nl

P1433

Q43115752-98A35C20-62FF-4669-B96D-257CCDEDEEB8

P1476

Q43115752-04289B7E-86E0-445E-9779-28B9AB7607F0

P2093

Q43115752-0D02EFCA-4BB9-4F86-A43A-6A71A967803C

Q43115752-1684DACF-2E67-4D04-95EC-C074B17EECFB

Q43115752-34D5FBC0-7409-485D-BAAC-C92BE4D71263

Q43115752-3775E749-A39E-4884-9D71-F3B7F37FC010

Q43115752-3E65931C-DD1F-4D5E-AF58-28FC750813FB

Q43115752-51AD730D-0474-49B6-AE98-0B7B37B112BE

Q43115752-62055B17-21BB-40EB-BF34-F009D1B02113

Q43115752-75AD74AA-3D95-43DD-A95D-BF90CDFA0A8F

Q43115752-8666F76C-6922-4763-BB9E-3ED880EE7C0E

Q43115752-8B6D28A6-3729-496C-B7B9-E48D633DB6CF

P2860

Q43115752-07130925-89C2-456A-9FF3-694A1FF7F234

Q43115752-0EEBB3A9-2A09-4A7B-8C74-2BD18842AFA8

Q43115752-169DF9FA-1BFA-4427-B68D-7CA41FC2F3FF

Q43115752-2CDFE7BA-F42A-4AE4-BCB8-46B7A86E530C

Q43115752-36490EA6-A2A3-4322-ABAD-A921059A7776

Q43115752-3FAC79FF-ED94-47F4-85BD-31E5AF2738AE

Q43115752-495B7B99-C430-4B4A-87D7-476B96BA9EFB

Q43115752-49A607F8-6667-494D-8FC2-D3DF274A786A

Q43115752-5AFD626D-CF4B-4874-83A6-79BB4AF21EBC

Q43115752-6D863370-0255-4C94-9BC0-36932DCE0E17

P304

Q43115752-DA639A5E-A78E-46A3-BA41-2436E543DE32

P31

Q43115752-C90EB20C-8B0D-4883-8319-97CE7836756D

P356

Q43115752-11FB0A5E-049D-460B-A06F-AF061A409163

P407

Q43115752-ECE243ED-F5C9-44A5-B29D-F336294105A2

P433

Q43115752-8B9C6DA8-9165-441A-8782-DFA4B50E8C60

P478

Q43115752-C6CAEF8B-EAF7-4F2D-9AFB-01AB7EA82A7C

P50

Q43115752-1B6E7C37-56F1-4A5A-AC56-848D7B9DFCAB

Q43115752-269F8B5E-2ACC-444D-9C41-062AE8CE6598

Q43115752-55F8C394-5829-4F41-8919-E78CDA023AB9

Q43115752-7AD0EC6D-BC6A-4CE8-81CC-EE990E8205F6

Q43115752-9478C0D2-AFD3-4CE0-9B57-9908198E70B4

P577

Q43115752-22EB4BAB-DE18-4497-B4C3-0CA7F9BABCD8

P5875

Q43115752-696B754D-C848-4158-8435-FFF1723C5033

P698

Q43115752-B0AB6E58-469E-4375-80FA-396B7E0AAE26

P932

Q43115752-5D0C8272-60E6-4B85-8B9A-066FDF608BC8

P356

P1433

Cancer Medicine

P1476

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

@en

P2093

Aristotle Bamias

http://www.w3.org/2001/XMLSchema#string

David M Berman

http://www.w3.org/2001/XMLSchema#string

Edward C Stack

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Guancial

http://www.w3.org/2001/XMLSchema#string

Fabio A Schutz

http://www.w3.org/2001/XMLSchema#string

Franziska Michor

http://www.w3.org/2001/XMLSchema#string

Joaquim Bellmunt

http://www.w3.org/2001/XMLSchema#string

Justine A Barletta

http://www.w3.org/2001/XMLSchema#string

Lillian Werner

http://www.w3.org/2001/XMLSchema#string

Michelle S Hirsch

http://www.w3.org/2001/XMLSchema#string

P2860

High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays

Profiling critical cancer gene mutations in clinical tumor samples

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions.

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

P304

835-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.262

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Philip W. Kantoff

Jonathan E Rosenberg

Levi A Garraway

P577

2014-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262573103

http://www.w3.org/2001/XMLSchema#string

P698

24846059

http://www.w3.org/2001/XMLSchema#string

P932

4303151

http://www.w3.org/2001/XMLSchema#string